FIELD: veterinary medicine.
SUBSTANCE: invention relates to veterinary virology and biotechnology. Vaccine containing avirulent and purified antigenic material from the FMD virus A (foot-and-mouth disease virus) strain No. 2269/ARRIAH/2015 has been developed. Antigenic material is a suspension containing predominantly 146S and 75S immunogenic components of FMD virus.
EFFECT: vaccine is able to provide effective protection against the homologous infectious agent circulating in the countries of the Transcaucasus, the Central Asia, and the Middle and the Near East.
9 cl, 8 tbl, 1 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE TYPE A | 2017 |
|
RU2665850C1 |
| INACTIVATED SORPTIVE VACCINE TO FMD TYPES A, O, ASIA-1 | 2015 |
|
RU2603003C1 |
| INACTIVATED SORBED VACCINE AGAINST FMD OF TYPE A | 2014 |
|
RU2563345C1 |
| A N2269/VNIIZZH/2015 STRAIN OF TYPE A APHTAE EPIZOOTICAE FOOT-AND-MOUTH DISEASE VIRUS FOR CONTROL OF ANTIGENIC AND IMMUNOGENIC ACTIVITY AND FOR MANUFACTURE OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF TYPE A FOOT-AND-MOUTH DISEASE | 2016 |
|
RU2640261C1 |
| INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE TYPES A, O, ASIA-1 | 2015 |
|
RU2593718C1 |
| STRAIN OF FMD VIRUS Aphtae epizooticae OF TYPE A FOR CONTROLLING ANTIGENIC AND IMMUNOGENIC ACTIVITY AND FOR PRODUCTION OF BIOLOGICAL PREPARATIONS FOR DIAGNOSTICS AND SPECIFIC PROPHYLAXIS OF FMD OF TYPE A | 2014 |
|
RU2553219C1 |
| INACTIVATED SORPTIVE FOOT-AND-MOUTH DISEASE TYPE A VACCINE | 2014 |
|
RU2562547C1 |
| FMD CULTURE INACTIVATED SORBED VACCINE FROM A/Iran/2018 STRAIN OF A/ASIA/Iran-05 NEW GENOTYPE | 2022 |
|
RU2799605C1 |
| CULTURE INACTIVATED SORBED VACCINE AGAINST FOOT AND MOUTH DISEASE FROM A/TANZANIA/2013 STRAIN OF A/AFRICA/G-I GENOTYPE | 2023 |
|
RU2815536C1 |
| VACCINE FOR EARLY PROTECTION AGAINST FOOT-AND-MOUTH DISEASE FROM STRAIN A 2205/G IV CULTURAL INACTIVATED EMULSION | 2021 |
|
RU2772713C1 |
